Mucuspen Overdose

How old is patient?
sponsored

What happens if I overdose Mucuspen?

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Mucuspen solution:

Store unopened vials of Mucuspen solution at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Mucuspen solution may be contaminated once opened. Store opened vials of undiluted medicine in the refrigerator between 36 and 46 degrees F (2 and 8 degrees C) for up to 4 days. Do not store in the bathroom. Keep Mucuspen solution out of the reach of children and away from pets.

Overdose of Mucuspen in details

sponsored

Single intravenous doses of Mucuspen at 1,000 mg/kg in mice, 2,445 mg/kg in rats, 1,500 mg/kg in guinea pigs, 1,200 mg/kg in rabbits and 500 mg/kg in dogs were lethal. Symptoms of acute toxicity were ataxia, hypoactivity, labored respiration, cyanosis, loss of righting reflex and convulsions.

What should I avoid while taking Mucuspen?

Do not mix other medicines in a nebulizer with Mucuspen inhalation, unless your doctor has told you to.

Mucuspen warnings

Mucuspen AS A MUCOLYTIC AGENT

After proper administration of Mucuspen, an increased volume of liquefied bronchial secretions may occur. When cough is inadequate, the airway must be maintained open by mechanical suction if necessary. When there is a mechanical block due to foreign body or local accumulation, the airway should be cleared by endotracheal aspiration, with or without bronchoscopy. Asthmatics under treatment with Mucuspen should be watched carefully. Most patients with bronchospasm are quickly relieved by the use of a bronchodilator given by nebulization. If bronchospasm progresses, the medication should be discontinued immediately.

Mucuspen AS AN ANTIDOTE FOR ACETAMINOPHEN OVERDOSAGE

Generalized urticaria has been observed rarely in patients receiving oral Mucuspen for acetaminophen overdose. If this occurs or other allergic symptoms appear, treatment with Mucuspen should be discontinued unless it is deemed essential and the allergic symptoms can be otherwise controlled. If encephalopathy due to hepatic failure becomes evident, Mucuspen treatment should be discontinued to avoid further administration of nitrogenous substances. There are no data indicating that Mucuspen influences hepatic failure, but this remains a theoretical possibility.

What should I discuss with my healthcare provider before taking Mucuspen?

Some medical conditions may interact with Mucuspen solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

Some MEDICINES MAY INTERACT with Mucuspen solution. However, no specific interactions with Mucuspen solution are known at this time.

Ask your health care provider if Mucuspen solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

Mucuspen precautions

sponsored

Mucuspen AS A MUCOLYTIC AGENT

General

With the administration of Mucuspen, the patient may observe initially a slight disagreeable odor that is soon not noticeable. With a face mask there may be stickiness on the face after nebulization. This is easily removed by washing with water.

Under certain conditions, a color change may occur in Mucuspen in the opened bottle. The light purple color is the result of a chemical reaction which does not significantly affect safety or mucolytic efficacy of Mucuspen.

Continued nebulization of Mucuspen solution (n-acetyl-l-cysteine) with a dry gas will result in an increased concentration of the drug in the nebulizer because of evaporation of the solvent. Extreme concentration may impede nebulization and efficient delivery of the drug. Dilution of the nebulizing solution with appropriate amounts of Sterile Water for Injection, USP, as concentration occurs, will obviate this problem.

Mucuspen AS AN ANTIDOTE FOR ACETAMINOPHEN OVERDOSAGE

Occasionally severe and persistent vomiting occurs as a symptom of acute acetaminophen overdose. Treatment with oral Mucuspen may aggravate the vomiting. Patients at risk of gastric hemorrhage (e.g., esophageal varices, peptic ulcers, etc.) should be evaluated concerning the risk of upper gastrointestinal hemorrhage versus the risk of developing hepatic toxicity, and treatment with Mucuspen given accordingly. Dilution of the Mucuspen for

Oral Administration

) minimizes the propensity of oral Mucuspen to aggravate vomiting.

Carcinogenesis, Mutagenesis and Impairment of Fertility

Carcinogenesis: Carcinogenicity studies in laboratory animals have not been performed with Mucuspen alone, nor with Mucuspen in combination with isoproterenol.

Long-term oral studies of Mucuspen alone in rats (12 months of treatment followed by 6 months of observation) at doses up to 1,000 mg/kg/day (5.2 times the human mucolytic dose) provided no evidence of oncogenic activity.

Mutagenesis: Published data1 indicate that Mucuspen is not mutagenic in the Ames test, both with and without metabolic activation.

Impairment of Fertility: A reproductive toxicity test to assess potential impairment of fertility was performed with Mucuspen (10%) combined with isoproterenol (0.05%) and administered as an aerosol into a chamber of 12.43 cubic meters. The combination was administered for 25, 30, or 35 minutes twice a day for 68 days before mating, to 200 male and 150 female rats; no adverse effects were noted in dams or pups. Females after mating were continued on treatment for the next 42 days.

Reproductive toxicity studies of Mucuspen in the rat given oral doses of Mucuspen up to 1,000 mg/kg (5.2 times the human mucolytic dose) have also been reported in the literature.1 The only adverse effect observed was a slight non-dose-related reduction in fertility at dose levels of 500 or 1,000 mg/kg/day (2.6 or 5.2 times the human mucolytic dose) in the Segment I study.

Pregnancy: Teratogenic Effects: Pregnancy Category B

Teratology: In a teratology study of Mucuspen in the rabbit, oral doses of 500 mg/kg/day (2.6 times the human mucolytic dose) were administered to pregnant does by intubation on days 6 through 16 of gestation. Mucuspen was found to be nonteratogenic under the conditions of the study.

In the rabbit, two groups (one of 14 and one of 16 pregnant females) were exposed to an aerosol of 10% Mucuspen and 0.05% isoproterenol hydrochloride for 30 or 35 minutes twice a day from the 16th through the 18th day of pregnancy. No teratogenic effects were observed among the offspring.

Teratology and a perinatal and postnatal toxicity study in rats were performed with a combination of Mucuspen and isoproterenol administered by the inhalation route. In the rat, two groups of 25 pregnant females each were exposed to the aerosol for 30 and 35 minutes, respectively, twice a day from the 6th through the 15th day of gestation. No teratogenic effects were observed among the offspring.

In the pregnant rat (30 rats per group), twice-daily exposure to an aerosol of Mucuspen and isoproterenol for 30 or 35 minutes from the 15th day of gestation through the 21st day postpartum was without adverse effect on dams or newborns.

Reproduction studies of Mucuspen with isoproterenol have been performed in rats and of Mucuspen alone in rabbits at doses up to 2.6 times the human dose. These have revealed no evidence of impaired fertility or harm to the fetus due to Mucuspen. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies may not always be predictive of human responses, this drug should be used during pregnancy only if clearly needed.

Nursing Mothers

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Mucuspen is administered to a nursing woman.

What happens if I miss a dose of Mucuspen?

Since this medicine is taken when needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


sponsored

Reviews

Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 4 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2024 ndrugs.com All Rights Reserved